Home Tags Pharmaceutical Industry
Tag: Pharmaceutical Industry
Merck said Thursday that it would lower the price of some of its medications including lowering the price of its hepatitis C drug Zepatier by 60%.
‘All sizzle and no steak’: Trump just claimed a win after striking a deal with Pfizer, but it could have zero impact on prescription drug ...
BI PRIME: Donald Trump has been making a stink about drug prices, claiming a win Tuesday night when Pfizer deferred its plan to increase the price of some medications. But the move might not play out to be the win Trump expects, especially for patients still facing high prescription drug costs.
Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1
Two months after it became the first federally approved drug of its kind to treat addiction, doctors are calling out Lucemyra, a new branded medication to treat opioid withdrawal, for costing $1,737 more per week than a similar generic drug.
"We have a contract with society, and society is our shareholder. A company like ours exists to have definitive impact on life threatening diseases, to keep people alive and healthy for a long, long time, full stop," Novartis executive Jay Bradner told Business Insider.
A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here’s what experts think
Sage Therapeutics CEO Jeff Jonas said the new drug could help depressed people feel well "with just a two week course of treatment — similar to how antibiotics are used." No existing drug works that way, and this one hasn't yet been studied beyond a limited time frame when most drugs fail.
A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect
GW Pharmaceutical's drug Epidiolex just became the first marijuana-based drug to win FDA approval. Studies suggest its active ingredient, CBD, reduces seizures in two rare types of epilepsy. The approval will likely galvanize future marijuana research.
How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors
Investors haven't been happy with Botox-maker Allergan in the past year. Here's how Allergan went from its start as a sleepy but beloved company out of Southern California in the 1950s to a target of investor angst today.
Embattled pharma company Valeant Pharmaceuticals is changing its name to Bausch Health Companies. The former stock market darling has had a rough couple of years after its pricing practices came under scrutiny in 2015. The name-change goes into effect in July.
How a city in Illinois decided to sue to combat high drug prices after realizing it was spending $500,000 on one drug
A recent "60 Minutes" episode highlighted a lawsuit between Rockford Illinois, and a drugmaker over the rising cost of prescription drugs that led to the city spending half a million dollars treating two babies.
A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift
Johnson & Johnson plans to file for FDA approval of a nasal formula of ketamine for depression this year. A new study presented on Saturday suggest the drug, called esketamine, is linked with some very positive results, especially in people with the hardest to treat forms of depression.